Literatur
- 1
Nuutinen M, Uhari M.
Recurrence and follow-up after urinary tract infection under the age of 1 year.
Pediatr Nephrol.
2001;
16
69-72
- 2
McCracken Jr G H.
Recurrent urinary tract infections in children.
Pediatr Infect Dis.
1984;
3 (3 Suppl.)
S28-S30
- 3
Kasanen A, Sundquist H et al.
Secondary prevention of urinary tract infections. The role of trimethoprim alone.
Ann Clin Res.
1983;
15 (Suppl. 36)
1-36
- 4
Helmholtz H F.
The effect of minimal ... high blood urea: report of case.
Proc Mayo Clin.
1941;
16
145
- 5
Stansfield J M, Webb J GG.
A plea for the longer treatment of chronic pyelonephritis in children.
Br Med J.
1954;
1
616-618
- 6
Marshall Jr. M, Johnson 3rd S H.
An initial report of the treatment of chronic urinary tract infection in children
with nitrofurantoin.
J Urol.
1956;
76
123-128
- 7
Smellie J M, Hodson C J et al.
Clinical and radiological features of urinary infection in childhood.
Br Med J.
1964;
2
1222-1226
- 8
Smellie J M, Gruneberg R N et al.
Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection:
clinical aspects.
Br Med J.
1976;
2
203-206
- 9
Smellie J M, Katz G et al.
Controlled trial of prophylactic treatment in childhood urinary-tract infection.
Lancet.
1978;
2
175-178
- 10
Lohr J A, Nunley D H et al.
Prevention of recurrent urinary tract infections in girls.
Pediatrics.
1977;
59
562-565
- 11
Smellie J M, Gruneberg R N et al.
Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection
in children.
Pediatr Nephrol.
1988;
2
12-17
- 12
Williams G, Lee A et al.
Antibiotics for the prevention of urinary tract infection in children: A systematic
review of randomized controlled trials.
J Pediatr.
2001;
138
868-874
- 13 Williams G J, Wei L et al. Long-term antibiotics for preventing recurrent urinary
tract infection in children.. Cochrane Database Syst Rev 3 2006. CD001534
- 14
Reddy P, Evans M T et al.
Antimicrobial prophylaxis with vesico-ureteral reflux: a randomized prospective study
of continuous therpay vs. intermittent therapy vs. surveillance.
Pediatrics.
1997;
100 (Suppl.)
555
- 15
Larcombe J.
Urinary tract infection in children.
BMJ.
1999;
319 (7218)
1173-1175
- 16
Le Saux N, Pham B et al.
Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections
in children: a systematic review.
CMAJ.
2000;
163
523-529
- 17
Wheeler D, Vimalachandra D et al.
Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled
trials.
Arch Dis Child.
2003;
88
688-694
- 18
Beetz R.
May we go on with antibacterial prophylaxis for urinary tract infections?.
Pediatr Nephrol.
2006;
21
5-13
- 19
Garin E H, Olavarria F et al.
Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis
after acute pyelonephritis: a multicenter, randomized, controlled study.
Pediatrics.
2006;
117
626-632
- 20
Roussey-Kesler G, Gadjos V et al.
Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in
children with low grade vesicoureteral reflux: results from a prospective randomized
study.
J Urol.
2008;
179
674-679; discussion 679
- 21
Montini G, Rigon L et al.
Prophylaxis after first febrile urinary tract infection in children? A multicenter,
randomized, controlled, noninferiority trial.
Pediatrics.
2008;
122
1064-1071
- 22
Pennesi M, Travan L et al.
Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing
pyelonephritis and renal scars? A randomized, controlled trial.
Pediatrics.
2008;
121
e1489-e1494
- 23
Brandström P, Esbjörner E, Herthelius M et al.
The Swedish Reflux Trial in Children: I. Study Design and Study Population Characteristics.
J Urol.
2010a;
184
274-279
- 24
Brandström P, Esbjörner E, Herthelius M et al.
The Swedish Reflux Trial in Children: III. Urinary Tract Infection Pattern.
J Urol.
2010b;
184
286-291
- 25
Brandström P, Neveus T, Sixt R et al.
The Swedish Reflux Study in Children: IV. Renal Damage.
J Urol.
2010c;
184
292-297
- 26
Holmdahl G, Brandström P, Läckgren G et al.
The Swedish Reflux Trial in Children: II. Vesicoureteral Reflux Outcome.
J Urol.
2010;
184
280-285
- 27
Sillen U, Brandström P, Jodal U et al.
The Swedish Reflux Trial in Children: V. Bladder Dysfunction.
J Urol.
2010;
184
298-304
- 28
Craig J.
Antibiotic prophylaxis and recurrent urinary tract infection in children.
New Engl J Med.
2009;
361
1748-1759
- 29
Ladhani S, Gransden W.
Increasing antibiotic resistance among urinary tract isolates.
Arch Dis Child.
2003;
88
444-445
- 30
Prere M F, Licznar P et al.
E. coli from urinary tract infections and acute pyelonephritis of children: 1 % of
strains are resistant to a subset of third generation cephalosporins.
Pathol Biol (Paris).
2004;
52
497-500
- 31
Marcus N, Ashkenazi S et al.
Non-Escherichia coli versus Escherichia coli community-acquired urinary tract infections
in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial
resistance and outcome.
Pediatr Infect Dis J.
2005;
24
581-585
- 32
Gokce I, Alpay H et al.
Urinary tract pathogens and their antimicrobial resistance patterns in Turkish children.
Pediatr Nephrol.
2006;
21
1327-1328
- 33
Anatoliotaki M, Galanakis E et al.
Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece.
Scand J Infect Dis.
2007;
39
671-675
- 34
Schmitt C P.
Keimspektrum und Resitenzlage bei Harnwegsinfektionen im Kindesalter.
Monatsschr Kinderheilkd.
2007;
155
228-233
- 35
Prelog M, Schiefecker D et al.
Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient
as empirical mono-therapy.
Pediatr Nephrol.
2008;
23
597-602
- 36
Greenfield S P, Chesney R W et al.
Vesicoureteral reflux: the RIVUR study and the way forward.
J Urol.
2008;
179
405-407
- 37
Keren R, Carpenter M A et al.
Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral
Reflux (RIVUR) study.
Pediatrics.
2008;
122 (Suppl. 5)
S240-S250
- 38
Caldamone A A.
Commentary to „Controversies in the management of vesicoureteral reflux – the rationale
for the RIVUR study”: Urinary tract infections and vesicoureteral reflux in childen:
What have we learned?.
J Pediatr Urol.
2009;
5
342-343
- 39
Mathews R, Carpenter M et al.
Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR
study.
J Pediatr Urol.
2009;
5
336-341
- 40
Bollgren I.
Antibacterial prophylaxis in children with urinary tract infection.
Acta Paediatr Suppl.
1999;
88
48-52
- 41
Haller M, Brandis M et al.
Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous
therapy.
Pediatr Nephrol.
2004;
19
982-986
- 42
Pape L, Gunzer F et al.
Bacterial pathogens, resistance patterns and treatment options in community acquired
pediatric urinary tract infection.
Klin Padiatr.
2004;
216
83-86
- 43
Lutter S A, Currie M L et al.
Antibiotic resistance patterns in children hospitalized for urinary tract infections.
Arch Pediatr Adolesc Med.
2005;
159
924-928
- 44
Smellie J M, Gruneberg R N et al.
Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood
urinary tract infection.
Rev Infect Dis.
1982;
4
461-466
- 45
Olbing H.
Trimethoprim bei Kindern mit HWI-Monotherapie oder Kombination (e. g. Cotrimoxazol).
Der Kinderarzt.
1993;
24
187-189
- 46
Towner K J, Pearson N J et al.
Increasing importance of plasmid-mediated trimethoprim resistance in enterobacteria:
two six-month clinical surveys.
Br Med J.
1980;
280
517-519
- 47
Kaneko K, Ohtomo Y et al.
Antibiotic prophylaxis by low-dose cefaclor in children with vesicoureteral reflux.
Pediatr Nephrol.
2003;
18
468-470
- 48
Bitsori M, Maraki S et al.
Resistance against broad-spectrum beta-lactams among uropathogens in children.
Pediatr Nephrol.
2009;
24
2381-2386
- 49
Cheng C H, Tsai M H et al.
Antibiotic resistance patterns of community-acquired urinary tract infections in children
with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Pediatrics.
2008;
122
1212-1217
- 50
Arya S C, Agarwal N et al.
Nitrofurantoin: an effective and ignored antimicrobial.
Int J Antimicrob Agents.
2006;
27
354-355
- 51
Kashanian J, Hakimian P et al.
Nitrofurantoin: the return of an old friend in the wake of growing resistance.
BJU Int.
2008;
102
1634-1637
- 52
Uhari M, Nuutinen M et al.
Adverse reactions in children during long-term antimicrobial therapy.
Pediatr Infect Dis J.
1996;
15
404-408
- 53
Karpman E, Kurzrock E A.
Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children.
J Urol.
2004;
172
448-453
- 54
Leung A K, Robson W L.
Urinary tract infection in infancy and childhood.
Adv Pediatr.
1991;
38
257-285
- 55
Westenfelder M, Vahlensieck W et al.
Patient compliance and efficacy of low-dose, long-term prophylaxis in patients with
recurrent urinary tract infection.
Chemioterapia.
1987;
6 (2 Suppl.)
530-532
- 56
Smolkin V, Haley R, Sakran W et al.
Compliance with antibiotic prophylaxis in urinary tract infections in children.
Pediatr Nephrol.
2007;
22
1451
- 57
Smyth A R, Judd B A.
Compliance with antibiotic prophylaxis in urinary tract infection.
Arch Dis Child.
1993;
68
235-236
- 58
Hellerstein S, Nickell E.
Prophylactic antibiotics in children at risk for urinary tract infection.
Pediatr Nephrol.
2002;
17
506-510
- 59
van Gool J D, Kuitjen R H et al.
Bladder-sphincter dysfunction, urinary infection and vesico-ureteral reflux with special
reference to cognitive bladder training.
Contrib Nephrol.
1984;
39
190-210
- 60
Koff S A, Wagner T T et al.
The relationship among dysfunctional elimination syndromes, primary vesicoureteral
reflux and urinary tract infections in children.
J Urol.
1998;
160 (3 Pt 2)
1019-1022
- 61
O’Regan S, Yazbeck S.
Constipation: a cause of enuresis, urinary tract infection and vesico-ureteral reflux
in children.
Med Hypotheses.
1985;
17
409-413
- 62
O’Regan S, Yazbeck S et al.
Constipation, bladder instability, urinary tract infection syndrome.
Clin Nephrol.
1985;
23
152-154
- 63
van der Plas R N, Benninga M A et al.
Randomised trial of biofeedback training for encopresis.
Arch Dis Child.
1996;
75
367-374
- 64
Loening-Baucke V.
Urinary incontinence and urinary tract infection and their resolution with treatment
of chronic constipation of childhood.
Pediatrics.
1997;
100 (2 Pt 1)
228-232
- 65
Bael A M, Benninga M A et al.
Functional urinary and fecal incontinence in neurologically normal children: symptoms
of one „functional elimination disorder”?.
BJU Int.
2007;
99
407-412
- 66
Beetz R, Bachmann H et al.
Urinary tract infections in infants and children – a consensus on diagnostic, therapy
and prophylaxis.
Urologe A.
2007;
46
112, 114 – 118, 120 – 123
- 67
Tönshoff B, Beetz R.
Antibiotische Dauerprophylaxe bei Harnwegsinfektionen: Wann, womit, wie lange?.
Monatsschr Kinderheilkd.
2007;
155
242-251
- 68
Montini G, Hewitt I.
Urinary tract infections: to prophylaxis or not to prophylaxis?.
Pediatr Nephrol.
2009;
24
1605-1609
- 69
Shiraishi K, Yoshino K et al.
Risk factors for breakthrough infection in children with primary vesicoureteral reflux.
J Urol.
2010;
183
1527-1531
- 70
Mingin G C, Nguyen H T et al.
Abnormal dimercapto-succinic acid scans predict an increased risk of breakthrough
infection in children with vesicoureteral reflux.
J Urol.
2004;
172
1075-1077; discussion 1077
- 71
Peters C, Skoog S J, Arant B S et al.
Summary of the AUA guideline on management of primary vesicoureteral reflux in children.
J Urol.
2010;
184
1134-1144
- 72
Ulman I, Jayanthi V R et al.
The long-term followup of newborns with severe unilateral hydronephrosis initially
treated nonoperatively.
J Urol.
2000;
164 (3 Pt 2)
1101-1105
- 73
Herndon C D.
Antenatal hydronephrosis: differential diagnosis, evaluation, and treatment options.
ScientificWorldJournal.
2006;
6
2345-2365
- 74
Herndon C D, Kitchens D M.
The management of ureteropelvic junction obstruction presenting with prenatal hydronephrosis.
ScientificWorldJournal.
2009;
9
400-403
- 75
Song S H, Lee S B et al.
Is antibiotic prophylaxis necessary in infants with obstructive hydronephrosis?.
J Urol.
2007;
177
1098-1101; discussion 1101
- 76
Walsh T J, Hsieh S et al.
Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the
first year of life.
Urology.
2007;
69
970-974
- 77
Coelho G M, Bouzada M C et al.
Risk factors for urinary tract infection in children with prenatal renal pelvic dilatation.
J Urol.
2008;
179
284-289
- 78
Lee J H, Choi H S et al.
Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection.
J Urol.
2008;
179
1524-1528
- 79
Gimpel C, Masioniene L et al.
Complications and long-term outcome of primary obstructive megaureter in childhood.
Pediatr Nephrol.
2010;
25
1679-1686
- 80
Roth C C, Hubanks J M et al.
Occurrence of urinary tract infection in children with significant upper urinary tract
obstruction.
Urology.
2009;
73
74-78
- 81
Madden N P, Thomas D F et al.
Antenatally detected pelviureteric junction obstruction. Is non-operation safe?.
Br J Urol.
1991;
68
305-310
- 82 Nicolle L E, Ronald A R. Recurrent urinary tract infection and its prevention..
In: Brumfitt W, Hamilton-Miller J MT, Bailey R R, eds. Urinary tract infections..
Cambridge: Chapman & Hall; 1998: 293-301
- 83 Albert X, Huertas I et al. Antibiotics for preventing recurrent urinary tract infection
in non-pregnant women.. Cochrane Database Syst Rev 3 2004. CD001209
- 84
Beetz R.
Antibakterielle Prophylaxe beim primären vesikoureteralen Reflux.
Monatsschr Kinderheilkd.
2008;
156
272-274
- 85 Beetz R, Kuwertz-Broking E et al. Harnwegsinfektionen. DGPI Handbuch Infektionen
bei Kindern und Jugendlichen.. Stuttgart, New York: Thieme; 2009: 622-663
- 86
Lebowitz R L, Olbing H et al.
International system of radiographic grading of vesicoureteric reflux. International
Reflux Study in Children.
Pediatr Radiol.
1985;
15
105-109
- 87
Brendstrup L, Hjelt K, Petersen K E et al.
Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infections
in children.
Acta Paediatr Scand.
1990;
79
1225-1234
- 88
Brumfitt W, Hamilton-Miller J MT.
Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18
years’ experience.
J Antimicrob Chemother.
1998;
42
363-371
- 89
Holmberg L, Bowman G, Bottiger L E et al.
Adverse reactions to nitrofurantoin: analysis of 921 reports.
Am J Med.
1980;
69
733-738
- 90
Coraggio M J, Gross T P, Roscelli J D.
Nitrofurantoin toxicity in children.
Pediatr Infect Dis J.
1989;
8
163-165
Priv.-Doz. Dr. med. Rolf Beetz
Zentrum für Kinder- und Jugendmedizin
Pädiatrische Nephrologie
Universitätsmedizin Mainz
Langenbeckstraße 1
55131 Mainz
Phone: 06131/173937
Fax: 06131/176693
Email: beetz@kinder.klinik.uni-mainz.de
